Patents by Inventor Enrico Albini

Enrico Albini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6583120
    Abstract: The present invention discloses an erythromycin derivative with antibiotic activity and pharmaceutically acceptable salts thereof, a process for their preparation and pharmaceutical compositions containing them as active principle.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: June 24, 2003
    Assignee: Zambon Group S.A.
    Inventors: Franco Pellacini, Daniela Botta, Stefano Romagnano, Enrico Albini, Domenico Ungheri, Giovanna Schioppacassi
  • Patent number: 6468979
    Abstract: Erythromycin derivatives with antibiotic activity and pharmaceutically acceptable salts thereof. A process for preparing such erythromycin derivatives and pharmaceutical compositions containing them as the active principle.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: October 22, 2002
    Assignee: Zambon Group S.p.A.
    Inventors: Franco Pellacini, Daniela Botta, Enrico Albini, Domenico Ungheri
  • Patent number: 6103909
    Abstract: Compounds of formula ##STR1## wherein R.sub.1 is chloro, fluoro, bromo or trifluoromethyl;R.sub.2 is hydrogen, chloro , fluoro, bromo or trifluoromethyl;Z is CH or N;R.sub.3, R.sub.4 and R.sub.5, which are the same or different, are hydrogen or C.sub.1 -C.sub.4 alkyl, with the proviso that R.sub.4 is different from R.sub.5 when R.sub.3 is hydrogen;X is O, S, SO or SO.sub.2 ;R.sub.6 is a C.sub.1 -C.sub.5 polyfluoroalkyl group containing at least two fluorine atoms and optionally other halogen atoms selected from the group consisting of chloro and bromo; processes for their preparation and pharmaceutical compositions containing them are described.The compounds of formula II-A are endowed with a marked wide range antimycotic acitivity.
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: August 15, 2000
    Assignee: Isagro S.p.A. and Zambon Group S.p.A.
    Inventors: Mauro Napoletano, Cristina Fraire, Enrico Albini, Giovanna Schioppacassi
  • Patent number: 5869512
    Abstract: Compounds of formula ##STR1## wherein R.sub.1 is chloro, fluoro, bromo or trifluoromethyl;R.sub.2 is hydrogen, chloro, fluoro, bromo or trifluoromethyl;Z is CH or N;R.sub.3, R.sub.4 and R.sub.5, which are the same or different, are hydrogen or C.sub.1 -C.sub.4 alkyl, with the proviso that R.sub.4 is different from R.sub.5 when R.sub.3 is hydrogen;X is O, S, SO or S0.sub.2 ;R.sub.6 is a C.sub.1 -C.sub.5 polyfluoroalkyl group containing at least two fluorine atoms and optionally other halogen atoms selected from the group consisting of chloro and bromo; processes for their preparation and pharmaceutical compositions containing them are described.The compounds of formula II-A are endowed with a marked wide range antimycotic acitivity.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: February 9, 1999
    Assignees: Zambon Group S.p.A, Isagro S.p.A.
    Inventors: Mauro Napoletano, Cristina Fraire, Enrico Albini, Giovanna Schioppacassi
  • Patent number: 5847092
    Abstract: Erythromycin 9-oxime derivatives wherein a phenyl or heterocylic group is attached indirectly to the 9-position of erythromycin A through an alkylene diamine bridging member. These compounds exhibit broad spectrum antibiotic activity.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: December 8, 1998
    Assignee: Zambon Group S.p.A.
    Inventors: Franco Pellacini, Giovanna Schioppacassi, Enrico Albini, Daniela Botta, Stefano Romagnano, Francesco Santangelo
  • Patent number: D319367
    Type: Grant
    Filed: December 21, 1988
    Date of Patent: August 27, 1991
    Assignee: Flash 2 -Studio di Pubblicita di E. Albini & G. C. Garda S.n.c.
    Inventors: Gian C. Garda, Enrico Albini